Butyrophilins Role in Colon Cancer

Recruiting now · Not applicable

Conditions studied: Colonic Cancer

In brief

quantification of BTNL molecules in colon cancer in order to determinate if their could be used as a prognostic marquer

Key facts

Study ID

NCT04185272

Run by

Institut Paoli-Calmettes

People needed

200

Starts

2020-06-30

Expected to finish

2028-06-01

Last updated by the study team

2025-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is older than 18 years old,
• Signed participation consent,
• Non-metastatic colon cancer immediately resectable or metastatic and liver synchronous for which it was decided a combined colic and liver surgery (metastatic patient at the outset) in multidisciplinary consultation meeting.
• Performance Status (PS) 0 or 1
• affiliated to the social security or beneficiary

You may not qualify if…

• Rectal cancer, colon cancer recurrence
• Emergency of colon cancer Surgery
• History of inflammatory disease of the digestive tract (Crohn's disease or ulcerative colitis)
• Patient who received neoadjuvant therapy other than chemotherapy
• Patient treated with immune-suppressors or long-course corticosteroids <12 months
• Pregnant women or likely to be pregnant (without effective contraception) or breastfeeding,
• Person in urgent situation, person under legal protection measure, or unable to express his / her consent,
• Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons

Where it is running

• Institut Paoli-Calmettes — Marseille, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.